GSK (NYSE:GSK) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.17 by 6.84 percent. This is a 10.62 percent increase over earnings of $1.13 per share from the same period last year. The company reported quarterly sales of $10.222 billion which beat the analyst consensus estimate of $10.190 billion by 0.31 percent. This is a 8.04 percent increase over sales of $9.461 billion the same period last year.